ctrl K

Watchlist Price Alert

Jasper Therapeutics Inc. (JSPR)

NASDAQ: JSPR · Real-Time Price · USD

5.54

-0.03 (-0.54%)

At close: Jun 13, 2025, 3:59 PM

5.50

-0.63%

After-hours: Jun 13, 2025, 07:49 PM EDT

Jasper Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	1.11M	1.31M	n/a	n/a	n/a
Gross Profit	n/a	-1.11M	-1.31M	-566K	-21K	n/a
Operating Income	-76.24M	-68.86M	-51.2M	-36.83M	-20.68M	-4.71M
Interest Income	5.06M	5.2M	n/a	n/a	n/a	533.00
Pretax Income	-72.76M	-66.09M	-37.69M	-30.64M	-31.67M	-4.99M
Net Income	-71.27M	-64.47M	-37.69M	-30.64M	-31.67M	-4.99M
Selling & General & Admin	20.42M	17.08M	16.57M	11.41M	4.8M	1.09M
Research & Development	55.82M	51.78M	34.63M	25.42M	15.88M	3.62M
Other Expenses	n/a	n/a	586K	n/a	n/a	n/a
Operating Expenses	76.24M	68.86M	51.2M	36.83M	20.68M	4.45M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	76.24M	68.86M	51.2M	36.83M	20.68M	4.71M
Income Tax Expense	-1.49M	-1.63M	-13.51M	-6.65M	-38.45K	-277
Shares Outstanding (Basic)	14.59M	10.44M	3.65M	1.14M	3.78M	n/a
Shares Outstanding (Diluted)	14.59M	10.44M	3.65M	1.14M	3.78M	n/a
EPS (Basic)	-4.89	-6.18	-10.3	-26.9	-114.3	n/a
EPS (Diluted)	-4.89	-6.18	-10.3	-26.9	-114.3	n/a
EBITDA	-71.39M	-64.98M	-38.21M	-31.17M	-31.95M	-277K
EBIT	-72.76M	-66.09M	-39.52M	-31.73M	-31.97M	-4.71M
Depreciation & Amortization	1.37M	1.11M	975K	377K	21K	4.71M